Takeda Pharmaceuticals filed suit against Camber Pharmaceuticals, Hetero Drugs, and Invagen Pharmaceuticals over seven patents related to antidiabetic drugs. 11/16, Southern District of New York, 1:2011cv08302.
Access to the full article is currently available to RPX members only. Please contact us if you need further information.
